Search research articles
Contact Us
Filters
Showing results (81-90 of 585) with videos related to
Page
of 59
Sort By:
The Annals of Pharmacotherapy
|
June 22, 2014
Reconciling Multiple Hypertension Guidelines to Promote Effective Clinical Practice
Marissa Salvo, C Michael White
Cardiac Electrophysiology Review
|
November 18, 2003
Amiodarone prevents symptomatic atrial fibrillation and reduces the risk of cerebrovascular accidents and ventricular tachycardia after open heart surgery: results of the Atrial Fibrillation Suppression Trial (AFIST)
Jeffrey Kluger, C Michael White
Connecticut Medicine
|
August 30, 2006
The use of intravenous amiodarone for chemical conversion of atrial fibrillation
Krista Dale, C Michael White
Parasitology International
|
April 30, 2022
Potential role of vaccines in elimination of Plasmodium vivax
Michael White, Chetan E Chitnis
Connecticut Medicine
|
April 3, 2004
Hawthorn
Bokyung Min, C Michael White
Journal of Managed Care Pharmacy : JMCP
|
July 26, 2011
Summary of AHRQ's comparative effectiveness review of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers added to standard medical therapy for treating stable ischemic heart disease
C Michael White, Laurence Greene
Connecticut Medicine
|
January 1, 2005
Adjunctive intravenous magnesium to reduce toxicity and enhance efficacy of class III antiarrhythmic agents
Nickole Henyan, C Michael White
Connecticut Medicine
|
March 23, 2005
The use of prophylactic amiodarone after cardiothoracic surgery reduces the incidence of atrial fibrillation
Stephen Sander, C Michael White
The Annals of Pharmacotherapy
|
October 21, 2016
Novel Use of Ranolazine as an Antiarrhythmic Agent in Atrial Fibrillation
C Michael White, Elaine Nguyen
JAMA
|
November 23, 2021
Risk of N-Nitrosodimethylamine (NMDA) Formation With Ranitidine-Reply
C Michael White, Adrian V Hernandez
Page
of 59
Search research articles
Search
Showing results (81-90 of 585) with videos related to
Sort By:
Page
of 59
The Annals of Pharmacotherapy
|
June 22, 2014
Reconciling Multiple Hypertension Guidelines to Promote Effective Clinical Practice
Marissa Salvo, C Michael White
Cardiac Electrophysiology Review
|
November 18, 2003
Amiodarone prevents symptomatic atrial fibrillation and reduces the risk of cerebrovascular accidents and ventricular tachycardia after open heart surgery: results of the Atrial Fibrillation Suppression Trial (AFIST)
Jeffrey Kluger, C Michael White
Connecticut Medicine
|
August 30, 2006
The use of intravenous amiodarone for chemical conversion of atrial fibrillation
Krista Dale, C Michael White
Parasitology International
|
April 30, 2022
Potential role of vaccines in elimination of Plasmodium vivax
Michael White, Chetan E Chitnis
Connecticut Medicine
|
April 3, 2004
Hawthorn
Bokyung Min, C Michael White
Journal of Managed Care Pharmacy : JMCP
|
July 26, 2011
Summary of AHRQ's comparative effectiveness review of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers added to standard medical therapy for treating stable ischemic heart disease
C Michael White, Laurence Greene
Connecticut Medicine
|
January 1, 2005
Adjunctive intravenous magnesium to reduce toxicity and enhance efficacy of class III antiarrhythmic agents
Nickole Henyan, C Michael White
Connecticut Medicine
|
March 23, 2005
The use of prophylactic amiodarone after cardiothoracic surgery reduces the incidence of atrial fibrillation
Stephen Sander, C Michael White
The Annals of Pharmacotherapy
|
October 21, 2016
Novel Use of Ranolazine as an Antiarrhythmic Agent in Atrial Fibrillation
C Michael White, Elaine Nguyen
JAMA
|
November 23, 2021
Risk of N-Nitrosodimethylamine (NMDA) Formation With Ranitidine-Reply
C Michael White, Adrian V Hernandez
Page
of 59